Quick Answer
Autolus Therapeutics plc reported Total Assets of $589.07 million for fiscal year 2025.
Autolus Therapeutics plc Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $589.07M | -24.7% |
| 2024 | $782.73M | +108.5% |
| 2023 | $375.38M | -7.6% |
| 2023 | $406.10M | -10.0% |
| 2023 | $450.99M | -2.0% |
| 2023 | $459.97M | -6.2% |
| 2022 | $490.27M | +85.8% |
| 2022 | $263.83M | -16.0% |
| 2022 | $313.98M | -13.7% |
| 2022 | $363.99M | -10.2% |
| 2021 | $405.56M | +37.8% |
| 2020 | $294.24M | -3.1% |
| 2019 | $303.53M | +19.4% |
| 2018 | $254.21M | -7.0% |
| 2018 | $273.20M | +91.4% |
| 2017 | $142.72M | -4.0% |
| 2017 | $148.66M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $661.95M | -20.0% | -8.2% |
| June 30, 2025 | $720.98M | -15.5% | -3.4% |
| March 31, 2025 | $746.34M | -17.2% | -4.6% |
| December 31, 2024 | $782.73M | +108.5% | -5.4% |
| September 30, 2024 | $827.49M | +103.8% | -3.1% |
| June 30, 2024 | $853.62M | — | -5.3% |
| March 31, 2024 | $901.44M | — | +140.1% |
| December 31, 2023 | $375.38M | -23.4% | -7.6% |
- Autolus Therapeutics plc showed a decrease of -24.7% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Autolus Therapeutics plc’s total assets has grown by 296.2% (from $148.66 million to $589.07 million).
- The most recent figure is from Autolus Therapeutics plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: